Texas – February 17, 2004
“We are pleased to announce today’s Washington Post article on low-level
laser therapy (“LLLT”) entitled “The Light Stuff” in which our company
was featured,” said Michael Barbour, president of MicroLight Corporation
of America. “The article can be viewed in its full length on the
Washington Post website at http://www.washingtonpost.com,” explained Mr.
The Washington Post article gives a brief history of LLLT and brings the
story up to date, including news of the successful use of the MicroLight
ML830® by the New England Patriots prior to their recent Super Bowl
victory. “A registered nurse successfully treated more than 10 Patriot
players for tendon and muscle injuries, according to the article,”
reported Mr. Barbour.
“I personally trained the Patriot’s registered nurse, Ellen Spicuzza, in
the use of our ML830®,” said Barbour, “and I was pleased to see her
acknowledge the degree of success she claims and is quoted on in the
article, including her success with an injury of one Patriot described
as ‘a flaired-up sciatic nerve’.”
“The Washington Post reported that the ML830® was the first cold laser
device to receive FDA market clearance, in 2002,” said Mr. Barbour, “and
it also pointed to the General Motors study, involving use of the ML830®
to prove the use of LLLT as a viable alternative to surgery for carpal
tunnel syndrome,” he added.